Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2012; 18(17): 2026-2034
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2026
Figure 2
Figure 2 Serum activity of alanine aminotransferase, alkaline phosphatase and aspartate aminotransferase of hepatic fibrosis patients and controls. A: Serum activity of alanine aminotransferase (IU/L) of hepatic fibrosis patients and controls; B: Serum activity of aspartate aminotransferase (IU/L) of hepatic fibrosis patients and controls; C: Serum activity of alkaline phosphatase (IU/L) of hepatic fibrosis patients and controls. aP < 0.05, cP < 0.05, eP < 0.05 vs before treatment and conventional group; Data are presented as mean ± SD. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; AHM: Aloe vera high molecular weight fractions.